ArticleJournal of hepatocellular carcinoma2026
Identification of a Prognostic Gene Signature Based on Lenvatinib Resistance in Hepatocellular Carcinoma with Functional Validation of the Key Gene CPB2.
Kan Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.